Ray Therapeutics Funding: $230M Raised, Series B (2026)

Ray Therapeutics funding overview

Ray Therapeutics is based in Berkeley, California. Ray Therapeutics has raised $230M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2026. The round record for Ray Therapeutics runs through 2026; nothing later has been disclosed. Investors on record include Janus Henderson Investors, Adage Capital Management, Franklin Templeton, Invus, Marshall Wace, 4BIO Capital and 5 others. 11 distinct backers are named across the disclosed rounds.

Ray Therapeutics at a glance

Total raised: $230M
Latest round: Series B
Latest round date: January 2026
Headquarters: Berkeley, California
Notable investors: Janus Henderson Investors, Adage Capital Management, Franklin Templeton, Invus, Marshall Wace, 4BIO Capital, Deerfield Management, MRL Ventures Fund

Frequently asked about Ray Therapeutics funding

How much has Ray Therapeutics raised?: Ray Therapeutics has raised $230M in total disclosed funding across the rounds on record.
Who has invested in Ray Therapeutics?: Janus Henderson Investors, Adage Capital Management, Franklin Templeton, Invus, Marshall Wace, 4BIO Capital are named among the investors backing Ray Therapeutics.
What was the latest Ray Therapeutics funding round?: The most recent disclosed round is a Series B, announced in January 2026.
Where is Ray Therapeutics based?: Ray Therapeutics is based in Berkeley, California.
When did Ray Therapeutics last raise?: The last disclosed Ray Therapeutics round closed in January 2026 at Series B.

Ray Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Berkeley below to benchmark round size and investor mix.

Ray Therapeutics Funding: $230M Raised, Series B (2026)

Ray Therapeutics funding overview

Ray Therapeutics at a glance

Frequently asked about Ray Therapeutics funding

Companies related to Ray Therapeutics (36)

Browse related funding lists (9)